Lawrence A. Rheins Ph.D.
Chief Scientific Officer
Dr. Rheins brings 25 plus years of experience in cosmetic, over-the-counter, prescription, and cosmetic dermatology (aesthetics). Most recently he served as Chief Scientific Officer for Aubio Life Sciences, a John Paul DeJoria company focused on the use of plant derivatives for treating common viral infections. Prior to Aubio, Dr. Rheins served as President/CEO for Makucell Inc, a USC spin-off focused on stem-cell derived physician-dispensed skincare products. In 2008 he served as President of Histogen Aesthetics, biotechnology company utilizing neonatal cells to develop a growth factor rich cultured medium for use in physician-dispensed skincare products.
Dr. Rheins founded and served as CEO for Dermtech International, a biotechnology company focused on the development of non-invasive biopsy technology for use in all areas of dermatology. He was Executive Director at Advanced Tissue Sciences and served as a divisional toxicologist for Procter & Gamble. Dr. Rheins holds several patents and has authored more than 70 articles on immunology, toxicology, cosmetics, and dermatology. He received his MS and Ph.D. degrees (immunology) from the University of Cincinnati.